Advancing Treatment Evaluation in Progressive Multiple Sclerosis: Interim Patient-Reported Outcomes for MAMS Clinical Trials
This article reviews the development and validation of patient-reported outcome measures as interim endpoints in multi-arm multistage trials for progressive multiple sclerosis, highlighting their potential to accelerate therapeutic development.